Clinical trials
Age clinical trials
Below are recruiting age clinical trials, each written for real people, not researchers. We’re tracking 1,307 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT01306019RecruitingPhase 1/Phase 2
Gene therapy for children with severe immune deficiency (XSCID)
This trial tests a one-time gene therapy approach to help children with X-linked SCID (a serious inherited immune disorder) make better immune cells. It’s for people who don’t have a fully matched sibling donor and need long-term follow-up after treatment.
Bethesda, MarylandAges 2–50 - NCT02419274Recruiting
Asthma group study for adults in Germany
This study follows adults with asthma to better understand the disease and help improve care. It checks basic eligibility such as diagnosis, language, and recent health history.
GroßhansdorfAges 18–99 - NCT02831335Recruiting
Multi-part kidney-to-brain MRI method study development
This study is testing an MRI (brain/scanner imaging) method that uses several measurements to learn more about connections between kidney and brain. You may be asked to undergo MRI scans, and you’ll need to meet safety and health criteria to participate.
Minneapolis, MinnesotaAges 21–80 - NCT02533804Recruiting
Life Project study for adults in Lake Nona
This study is collecting information from adults living or working in the Lake Nona area. It may help researchers understand community needs and improve programs for residents.
Orlando, FloridaAges 18–110 - NCT02669953Recruiting
Aflibercept injections for persistent wet macular degeneration
This trial studies whether aflibercept injections can help when “wet” age-related macular degeneration is recurring or not fully going away. It focuses on adults who have already had ranibizumab and still have measurable vision in the study eye.
ViennaAges 50 years+ - NCT02253030Recruiting
Eye scan study for newly diagnosed wet AMD
This study uses a special eye scan (OCT angiography) to look at new, abnormal blood vessel growth in people with wet age-related macular degeneration (wet AMD) who have not been treated yet. It may help researchers better understand the disease and how it changes over time.
Portland, OregonAges 50–100 - NCT02496468Recruiting
Study for children with wheezing or asthma symptoms
This study follows children with wheezing (in younger kids) or doctor-diagnosed asthma (in older kids). It aims to better understand asthma and related breathing problems and how they develop over time.
CologneAges 6 months–18 years - NCT02523118Recruiting
Measuring symptoms and test results in eosinophilic gut diseases
This study looks at how eosinophilic inflammation in the esophagus and intestines affects outcomes like symptoms and test findings. It may help clinicians better understand these conditions and track what changes over time.
Phoenix, ArizonaAges 3 years+ - NCT03366168Recruiting
Using tongue tissue to grow stem cells in adults
This study takes a small sample from the front of your tongue to grow stem cells from your taste-bud tissue. It aims to understand whether this approach can be safely done in healthy adults and explore how the cells might be used in the future.
Baltimore, MarylandAges 18–120 - NCT07632274RecruitingPhase 1
Testing a pain reliever liquid for children ages 6–11
This study tests a new liquid medicine that combines ibuprofen and acetaminophen (two common over-the-counter pain relievers) in children aged 6 to 11. Researchers want to see how well the medicine works and how safe it is for mild to moderate pain, such as headaches, toothaches, or pain after dental work or vaccines.
Salt Lake City, UtahAges 6–11 - NCT03011541Recruiting
Stem cell treatment for damaged retina or optic nerve
This study looks at stem-cell treatment to help vision in adults whose retina or optic nerve damage is not expected to improve on its own. You may be a candidate if your eye exam shows documented, stable or slowly changing damage and you can safely complete follow-up eye visits.
Westport, ConnecticutAges 18 years+ - NCT02497261Enrolling by invitation
Study factors that predict peanut allergy at age five
This study looks at which early test results and symptoms help predict whether a child will still have a peanut allergy by age 5. It may help families and doctors better understand who is at higher risk and plan next steps.
Ages 4–10 - NCT00950430Enrolling by invitationPhase 4
Brain scan study for amyloid plaques in adults
This study uses brain imaging to look for amyloid plaques (abnormal protein deposits) as people age. It may help researchers better understand how these changes develop over time.
Rochester, MinnesotaAges 30–100 - NCT01453127Enrolling by invitationPhase 4
DaTscan scan for aging and movement brain conditions
This trial uses a special brain scan called DaTscan to study how certain brain conditions change with aging and over time. It may help researchers better understand movement and other neurodegenerative conditions and who may benefit from future treatments.
Rochester, MinnesotaAges 40–90 - NCT07398495Recruiting
Exercise program for diabetes and muscle loss
This study tests whether a special exercise program can help middle-aged and older adults who have both type 2 diabetes and muscle loss. It aims to improve muscle strength, balance, and overall health.
Taichung, TaiwanAges 45–85 - NCT07399028Recruiting
Skin changes from biostimulator treatment in women
This study looks at how a biostimulator (a type of injectable treatment that helps your skin produce more collagen) changes your skin. Researchers will use special cameras and scans to see these changes, which may help reduce wrinkles on your cheeks.
New York, New YorkAges 45–65 - NCT07399808Recruiting
CDK4/6 Inhibitors in Older Breast Cancer Patients
This study looks at how well CDK4/6 inhibitors work in older adults with breast cancer who are taking these drugs after surgery to help prevent the cancer from coming back. It will follow patients over time to learn more about their experiences.
Pavia, PaviaAges 18 years+ - NCT07403825RecruitingPhase 4
Faricimab for wet AMD with subretinal material
This trial tests a new drug called Faricimab for people with a specific type of wet age-related macular degeneration (AMD) that has a buildup of material beneath the retina. The goal is to see if Faricimab can help clear this material and improve vision.
Córdoba, AndalusiaAges 50 years+ - NCT07404085Recruiting
Cognitive training with medication for mood disorders
This trial tests if a medication can boost the effects of cognitive training in people with bipolar disorder or recurrent depression who have memory or thinking problems. It aims to improve daily functioning.
Frederiksberg, Capital Region of DenmarkAges 40–75 - NCT07413159Recruiting
Check, monitor, control hypertension study
This 24-month trial tests whether combining pharmacist counseling with community health worker support helps African Americans aged 55+ better control their high blood pressure. You will receive extra guidance to manage your blood pressure at home.
Houston, TexasAges 55 years+ - NCT07413666RecruitingPhase 1
Safety study of ORX489 in healthy adults
This phase 1 trial is testing an experimental drug called ORX489 in healthy adults aged 18 to 60. The goal is to see if it is safe and how the body processes it, which helps decide if it can be tried in people with certain conditions.
Lincoln, NebraskaAges 18–60 - NCT07415759Recruiting
MRI study of electrical properties in healthy aging
This study uses MRI to measure electrical properties in the body and see how they change with age. It may help researchers better understand normal aging and develop future medical imaging techniques.
Vandœuvre-lès-Nancy, CHRU de NancyAges 6 years+ - NCT07416201Recruiting
Study of Immune System Aging in Down Syndrome
This study is looking at how the immune system changes over time in people with Down syndrome, and how it may be affected by removal of the thymus gland. The goal is to understand why people with Down syndrome may age faster or have different immune health.
Bethesda, MarylandAges 1–120 - NCT07416799Recruiting
Home strength training for diabetes and mild memory loss
This study tests whether a home strength-training program using a smartphone app is doable for older adults with type 2 diabetes who also have mild memory problems. You'll do simple exercises at home, and the program may help improve your thinking and glucose control.
Galveston, TexasAges 55–80
Hear when a new Age trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for age?
- Yes. Clin2 currently lists 1,307 recruiting age studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a age trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a age trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.